PURPOSE: To analyze the patterns of failure, the toxicity profile, and the factors influencing
efficacy of stereotactic body radiation (SBRT) for early-stage non-small-cell lung cancer …

Although stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy has
become an established standard of care for the treatment of a variety of malignancies, our …

Introduction: The use of stereotactic ablative radiotherapy (SABR) in centrally located early-
stage lung tumors has been associated with increased toxicity. We studied outcomes after …

PURPOSE: To identify the dose–volume parameters that predict the risk of chest wall (CW)
pain and/or rib fracture after lung stereotactic body radiotherapy. METHODS AND …

PURPOSE: To determine prognostic factors for local control of primary or metastatic tumors
within the lung or liver treated with stereotactic body radiation therapy (SBRT) within a single …

PURPOSE: To assess the body-framed stereotactic body radiation therapy (SBRT) results
and toxicity for medically inoperable stage I lung cancer adjacent to central large bronchus …

PURPOSE: To assess toxicity and feasibility of reirradiation with stereotactic body
radiotherapy (SBRT) after prior lung SBRT for primary lung cancer or lung metastases …

Stereotactic body radiation (SBRT) is an emerging tool in radiation oncology in which the
targeting accuracy is improved via the detection and processing of a three-dimensional …

To evaluate the current status of stereotactic body radiotherapy (SBRT) and identify both
advantages and disadvantages of its use in developing countries, a meeting composed of …

The clinical applications of stereotactic body radiotherapy or stereotactic ablative
radiotherapy (SABR) for the treatment of primary and metastatic tumours of different organ …